Martin Shkreli 'went on warpath' after he was booted as CEO
A scorned Martin Shkreli "went on the warpath" after being ousted as CEO by the board of the drug company he had founded, and threatened his successor, that current CEO testified Friday.
Shkreli said "I had never dealt with anyone like him," testified Retrophin (RTRX) CEO Stephen Aselage in Brooklyn, New York, federal court. Shkreli warned him, "My family and I would suffer as a result of my actions," said Aselage, as he described an October 2014 phone call with Shkreli after he was booted from the company.
"It was what I would consider a very threatening conversation," Aselage testified at Shkreli's securities fraud trial, where he also described a disturbing series of "red flags" that led to Shkreli being ousted.
He said Shkreli vowed to subject Aselage, who became chief executive after he was forced out, to "an unremitting wave of litigation."
Aselage said that afterward, "He went on the warpath, as I would describe it, to harm the company and damage the reputations of the people in the company."
Shkreli also told Retrophin investors he planned to produce a generic drug equivalent for one of Retrophin's products, which could harm company revenue, Aselage said.
"The defendant and three of his friends broke into the offices," Aselage said, and then downloaded files from Retrophin's computer servers.
http://www.msn.com/en-us/money/companies/martin-shkreli-went-on-warpath-after-he-was-booted-as-ceo/ar-BBEposM?li=BBnbfcN&ocid=edgsp